NCT04415944 2026-03-19
HIPEC
Wake Forest University Health Sciences
Phase 2 Completed
Clinical Trials
26 trialsNCT04761185 2026-02-25
Raltitrexed in HIPEC
Fudan University
Phase 1 Completed
NCT01226550 2025-12-19
Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan
Hospices Civils de Lyon
Phase 1/2 Completed
NCT02672098 2025-05-22
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Loma Linda University
Phase 1 Completed
NCT03422432 2025-02-03
Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
National Cancer Centre, Singapore
Phase NA Completed
NCT06697613 2024-11-20
Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Completed
NCT02040142 2024-10-24
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
Phase 2 Completed
NCT02891447 2024-09-19
Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02567253 2023-11-27
OvIP1
University Hospital, Ghent
Phase 2 Completed
NCT03514888 2023-08-28
HIPEC After Radical Cystectomy for High Risk Bladder Cancer
Weill Medical College of Cornell University
Phase NA Completed
NCT05547568 2022-10-21
A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?
CHU de Reims
Completed
NCT03604653 2022-08-03
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Holy Name Medical Center, Inc.
Completed
NCT02475772 2022-07-08
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
Ruhr University of Bochum
Phase 1 Completed
NCT02179489 2022-06-27
Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis
Zhejiang University
Phase NA Completed
NCT02158988 2021-07-29
GASTRIPEC
Charite University, Berlin, Germany
Phase 3 Completed
NCT02249013 2021-03-18
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
Professor Fernando Figueira Integral Medicine Institute
Phase 2 Completed
NCT03364907 2020-10-20
GUTOX
Radboud University Medical Center
Completed
NCT04135521 2020-06-29
Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer
Far Eastern Memorial Hospital
Completed
NCT02528110 2020-03-24
Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
Wuhan University
Phase 2 Completed
NCT02830139 2020-03-18
Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer
Wuhan University
Phase 2 Completed
NCT01277744 2020-01-13
Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02672865 2019-04-12
Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric Cancer
Loma Linda University
Phase 1 Completed
NCT01580410 2018-07-03
Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
Wake Forest University Health Sciences
Phase 2 Completed
NCT01709487 2016-02-24
Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy
Jules Bordet Institute
Phase 1/2 Completed
NCT00804258 2015-11-06
Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer
City of Hope Medical Center
Completed
NCT01588964 2012-05-01
IPHC
Catholic University of the Sacred Heart
Phase 2 Completed